Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The antigenic anatomy of SARS-CoV-2 receptor binding domain

GUPTA S. et al, (2021), Cell

Promises and challenges of adoptive T-cell therapies for solid tumours

AHMED A. et al, (2021), British Journal of Cancer

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2020), Nat Med

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2020), Nat Med

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Voysey M. et al, (2020), Lancet

Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases.

Yao X. et al, (2020), Breathe (Sheff), 16

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.

National SARS-CoV-2 Serology Assay Evaluation Group None., (2020), Lancet Infect Dis, 20, 1390 - 1400

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Ramasamy MN. et al, (2020), Lancet

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

Peng Y. et al, (2020), Nat Immunol, 21, 1336 - 1345

IFITM3-specific antibody reveals interferon preferences and slow interferon induction of the anti-viral factor IFITM3 in humans

WELLINGTON D. et al, (2020), European Journal of Immunology

Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.

Kanellakis NI. et al, (2020), Thorax

Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro

Asciak R. et al, (2020), EUROPEAN RESPIRATORY JOURNAL, 56

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Folegatti PM. et al, (2020), Lancet, 396, 467 - 478

Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.

Zhao Y. et al, (2020), JCI Insight, 5

Human cancer germline antigen-specific cytotoxic T cell-what can we learn from patient.

Abd Hamid M. et al, (2020), Cell Mol Immunol, 17, 684 - 692

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.

Peng Y. et al, (2020), bioRxiv

A novel scoring system for prediction of disease severity in COVID-19

DONG TAO., (2020), Frontiers in Cellular and Infection Microbiology, section Virus and Host

Longitudinal profiling of cytokines and chemokines in COVID-19 reveals inhibitory mediators IL-1Ra and IL-10 are associated with disease severity while elevated RANTES is an early predictor of mild disease

DONG TAO. et al, (2020), Preprint with Lancet

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19

Zhang Y. et al, (2020), The Journal of Infectious Diseases

Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.

Song R. et al, (2020), J Infect

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?